Back
Theriva Biologics Stock Price Chart
The Next Tech Giant in Your Pocket?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
74
TOVX
Theriva Biologics
Last Price:
3.89
Seasonality Move:
-14.26%
7 Day Trial
ALL ACCESS PASS
$
7
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TOVX is experiencing slight selling pressure.
Theriva Biologics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.88 | Sell |
| 20-day SMA: | 3.73 | Buy |
| 50-day SMA: | 1.63 | Buy |
| 200-day SMA: | 0.72 | Buy |
| 8-day EMA: | 3.86 | Sell |
| 20-day EMA: | 3.36 | Buy |
| 50-day EMA: | 2.2 | Buy |
| 200-day EMA: | 1 | Buy |
Theriva Biologics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.69 | Buy |
| Relative Strength Index (14 RSI): | 45.75 | Sell |
| Chaikin Money Flow: | -12459 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.32 - 4.72) | Buy |
| Bollinger Bands (100): | (-0.5 - 2.42) | Buy |
Theriva Biologics Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Theriva Biologics Stock
Is Theriva Biologics Stock a Buy?
- Theriva Biologics share price is 3.80 while TOVX 8-day simple moving average is 3.88, which is a Sell signal.
- The stock price of TOVX is 3.80 while Theriva Biologics 20-day SMA is 3.73, which makes it a Buy.
- Theriva Biologics 50-day simple moving average is 1.63 while TOVX share price is 3.80, making it a Buy technically.
- TOVX stock price is 3.80 and Theriva Biologics 200-day simple moving average is 0.72, creating a Buy signal.
TOVX Technical Analysis vs Fundamental Analysis
Buy
74
Theriva Biologics (TOVX)
is a Buy
Is Theriva Biologics a Buy or a Sell?
-
Theriva Biologics stock is rated a Buy
The current Theriva Biologics [TOVX] share price is $3.80. The Score for TOVX is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
Theriva Biologics Stock Info
Market Cap:
3.82M
Price in USD:
3.80
Share Volume:
146.2K
Theriva Biologics 52-Week Range
52-Week High:
17.11
52-Week Low:
2.67
Buy
74
Theriva Biologics (TOVX)
is a Buy
Theriva Biologics Share Price Forecast
-
What is the Theriva Biologics stock price today?
The Theriva Biologics stock price is 3.80 USD today. -
Will TOVX stock go up or go down?
Theriva Biologics> share price is forecast to RISE/FALL based on technical indicators -
Is Theriva Biologics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Theriva Biologics is not overvalued.
Is Theriva Biologics Stock a Buy?
- Theriva Biologics share price is 3.80 while TOVX 8-day exponential moving average is 3.86, which is a Sell signal.
- The stock price of TOVX is 3.80 while Theriva Biologics 20-day EMA is 3.36, which makes it a Buy.
- Theriva Biologics 50-day exponential moving average is 2.20 while TOVX share price is 3.80, making it a Buy technically.
- TOVX stock price is 3.80 and Theriva Biologics 200-day simple moving average is 1.00, creating a Buy signal.
Fundamental Analysis of Theriva Biologics
Is Theriva Biologics a good investment?
- Analysts estimate an earnings increase this quarter of $3.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.00 per share, and an increase next year of $22.60 per share.
Technical Analysis of Theriva Biologics
Should I short Theriva Biologics stock?
- TOVX Moving Average Covergence Divergence (MACD) indicator is 0.69, suggesting Theriva Biologics is a Buy
- Theriva Biologics Relative Strength Index (RSI) is 45.75, which suggest Theriva Biologics is oversold
- The Bollinger Bands (25) for Theriva Biologics is (1.32 - 4.72), which suggest Theriva Biologics is a Buy
- The Bollinger Bands (100) for Theriva Biologics is (-0.5 - 2.42), which suggest Theriva Biologics is a Buy
* Theriva Biologics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.